Discover

News & Info

Quote List Quote List

VeraDermics(MANE.US)

Event Tracking

Feb9

Veradermics Inc. Submits Beneficial Ownership Statement to SEC Confirming Suvretta Capital Management, LLC as Beneficial Owner

23:13

Veradermics Completes Phase III Clinical Trial Recruitment for Male Pattern Baldness Drug VDPHL01

12:42

Jan29

VeraDermics released FY2024 Q4 earnings on January 28 (EST), actual revenue USD 0, actual EPS USD -8.7864

04:00

VeraDermics released FY2023 Annual Earnings on January 28 (EST), Actual Revenue: USD 0, Actual EPS: USD -22.3765

04:00

VeraDermics released FY2024 Annual Earnings on January 28, 2026 (EST), with actual revenue of USD 0 and EPS of USD -37.0495

04:00

Schedules & Filings

Schedules

Filings

Jan28

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Net Income -6.475 M, EPS -8.7864

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More